First in vivo evidence of increased TSPO expression and inflammation in brains of patients with growing sporadic vestibular schwannomas

First in vivo evidence of increased TSPO expression and inflammation in brains of patients with growing sporadic vestibular schwannomas

Scientists from our brain tumour theme along with colleagues from the Manchester Centre for Clinical Neurosciences, part of Northern Care Alliance NHS Foundation Trust have published a paper in Neuro-Oncology Advances. It is the first in vivo evidence of increased TSPO expression and inflammation within the brains of patients with growing sporadic vestibular schwannomas. 

Major funding for heart and stroke research

Major funding for heart and stroke research

Manchester is one of nine leading universities which will benefit from a record £35 million funding injection from the British Heart Foundation (BHF) to help strengthen world-leading cardiovascular disease research in the UK. The funding comes from the highly competitive Research Excellence Awards funding scheme.

Study sheds new light on devastating brain tumour

Study sheds new light on devastating brain tumour

A team of researchers from The University of Manchester and the Geoffrey Jefferson Brain Research Centre have made an exciting discovery. This important research has been published in the prestigious journal Science Advances and could pave the way for new treatments in the future.

Podcast: Understanding NF2

Podcast: Understanding NF2

NF2-Related Schwannomatosis is a rare genetic condition affecting 1 in 33,000. Despite its impact, it remains lesser known. Our latest podcast episode shines a light on NF2, making the complex understandable.

North American Skull Base Society meeting

North American Skull Base Society meeting

The North American Skull Base Society meeting took place in Atlanta from 16-18 February. It was a fantastic forum for learning & discussion across the whole breadth of skull base surgery. Colleagues from the Jeff attended to give invited talks at the meeting.

Inaugural Jeff Showcase

Inaugural Jeff Showcase

Our inaugural showcase went ahead on Friday 19 January at The Hyatt Regency Manchester, the event was attended by over 150 delegates including academics, clinicians, students, people from industry, charities, and members of the public.

MRC Project Grant awarded to Dr. R. Wykes for evaluating stroke impact through graphene-enabled nanotechnology

MRC Project Grant awarded to Dr. R. Wykes for evaluating stroke impact through graphene-enabled nanotechnology

The team aims to bring this cutting-edge technology to preclinical stroke research to gain a better understanding of the mechanisms of SD initiation and their involvement in worsening stroke severity. This work will be a crucial first step in the maturity of this technology towards future clinical translation where they anticipate that it will greatly facilitate management of patients in the neuro-intensive care units.